feed,title,long_url,short_url
Benzinga,Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation,https://benzinga.com/general/biotech/21/09/23015848/exelixiss-cabometyx-scores-fda-nod-in-differentiated-thyroid-cancer-esmo-presentation,https://j.mp/3tZI1xs
